Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01764373 · ClinicalTrials.gov registry record · NA
Pilot Study of Exercise and Peripheral Nerve Function in People With Diabetes - ENRGy2 Addendum
A NA study, sponsored by University of Kansas.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT01764373: Completed NA study, sponsored by University of Kansas.
NCT01764373 is a NA study that has completed, run by University of Kansas. The registered enrollment target is 19 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01764373, a NA study, has completed, sponsored by University of Kansas.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
This is an amendment to study posting NCT00970060. Based on preliminary results from that study is was determined there needs to be a follow-up exercise intervention study. This study has two additional aims than the original study. The objectives are to determine is a prolonged exercise routine, 16-weeks, paired with refined measures of effectiveness positively impact people with diabetic neuropathy.
Primary Outcome
Change in nerve function will be quantified using the Total Neuropathy Score (TNS). The TNS is a composite measure of peripheral nerve function that includes grading of signs/symptoms, nerve conduction studies, and quantitative sensory testing. We will not include proprioceptive testing in this project.
Interventions
- OTHER Aerobic Exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2012-06 |
| Est. Completion | 2013-07 |
| Phase | NA |
What the finished NCT01764373 record still lists
NCT01764373 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Aerobic Exercise is the first listed.
NCT01764373 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01764373 about?
NCT01764373 is a clinical study titled "Pilot Study of Exercise and Peripheral Nerve Function in People With Diabetes - ENRGy2 Addendum". This is an amendment to study posting NCT00970060. Based on preliminary results from that study is was determined there needs to be a follow-up exercise intervention study. This study has two additional aims than the original study. The objectives are to determine is a prolonged exercise routine, 16...
What is the current status of trial NCT01764373?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2012-06. Estimated completion is 2013-07.
What interventions are being tested in trial NCT01764373?
The interventions under investigation include: Aerobic Exercise (OTHER).
Who is sponsoring clinical trial NCT01764373?
This trial is sponsored by University of Kansas, which has 66 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01764373's enrollment target sits among peer trials
19 1861st of 2000 higher than 138 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia